Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 501–600 of 1,000
Anti‐anxiety and sedative profile evaluation of imidazo[1,2‐a]pyridine derivatives
López‐Martínez, M., Salgado‐Zamora, H., Juan, E. R., Zamudio, S., Picazo, O., Campos, E., & Naranjo‐Rodríguez, E. B. (2010) · Drug Development Research · doi:10.1002/ddr.20382 · Cited by 26
Selective labelling of diazepam‐insensitive GABA A receptors in vivo using [ 3 H]Ro 15‐4513
Pym, L. J., Cook, S. M., Rosahl, T. W., McKernan, R. M., & Atack, J. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706392 · Cited by 26
Self-citationIdentification and characterization of anesthetic targets by mouse molecular genetics approaches
Drexler, B., Antkowiak, B., Engin, E., & Rudolph, U. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9414-1 · Cited by 26
Kessler, A., Villmann, C., Nadeem, H. Ş., Pischetsrieder, M., & Buettner, A. (2012) · Flavour and Fragrance Journal · doi:10.1002/ffj.3099 · Cited by 26
Taliani, S., Cosimelli, B., Settimo, F. D., Marini, A. M., Motta, C. L., Simorini, F., Salerno, S., Novellino, E., Greco, G., Cosconati, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9001154 · Cited by 26
Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice.
Navarro, J. F., Burón, E., & Martín‐López, M. (2006) · PubMed · Cited by 26
Nomura, T., Hawkins, N. A., Kearney, J. A., George, A. L., & Contractor, A. (2019) · The Journal of Physiology · doi:10.1113/jp277651 · Cited by 26
Warnault, V., Houchi, H., Barbier, E., Pierrefiche, O., Vilpoux, C., Ledent, C. A., Daoust, M., & Naassïla, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04577.x · Cited by 26
Wegner, F., Deuther‐Conrad, W., Scheunemann, M., Brust, P., Fischer, S., Hiller, A., Diekers, M., Strecker, K., Wohlfarth, K., Allgaier, C., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.016 · Cited by 26
Rabe, H., Kronbach, C., Rundfeldt, C., & Lüddens, H. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.013 · Cited by 26
Discovering new biology with drug-resistance alleles
Freedy, A. M., & Liau, B. B. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00865-9 · Cited by 25
Luo, Y., & Balle, T. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13798 · Cited by 25
Decreased GABA A and GABA B receptor functional activity in cannabinoid CB 1 receptor knockout mice
Urigüen, L., García‐Gutiérrez, M. S., & Manzanares, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358204 · Cited by 25
Tornberg, J., Segerstråle, M., Kulesskaya, N., Võikar, V., Taira, T., & Airaksinen, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301195 · Cited by 25
Witkin, J. M., Cerne, R., Wakulchik, M., S., J., Gleason, S. D., Jones, T. M., Li, G., Arnold, L. A., Li, J., Schkeryantz, J. M., et al. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.04.009 · Cited by 25
Huemer, H. P. (2015) · Mediators of Inflammation · doi:10.1155/2015/349176 · Cited by 25
Zolpidem Dependency and Withdrawal Seizure: A Case Report Study
Javadi, S. A. H. S., Hajiali, F., & Nassiri‐Asl, M. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.19926 · Cited by 25
Dubinsky, B., Vaidya, A. H., Rosenthal, D. I., Hochman, C., Crooke, J. J., DeLuca, S., Devine, A., Cheo-Isaacs, C. T., Carter, A. R., Jordan, A. D., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036954 · Cited by 25
Physiology and Pharmacology of the GABA System: Focus on GABA Receptors
Möhler, H. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_1 · Cited by 26
Actions at GABAA receptors in the hippocampus may mediate some antiseizure effects of progestins
Rhodes, M. E., & Frye, C. A. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.02.006 · Cited by 25
GABAA receptor polymorphisms in alcohol use disorder in the GWAS era
Koulentaki, M., & Kouroumalis, E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4918-4 · Cited by 24
Forebrain medial septum region facilitates nociception in a rat formalin model of inflammatory pain
Lee, A. T.-H., Ariffin, M. Z., Zhou, M., Ye, J. Z., Moochhala, S., & Khanna, S. (2011) · Pain · doi:10.1016/j.pain.2011.07.019 · Cited by 24
Mathiasen, L., Rodgers, R. J., & Mirza, N. R. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32814fcdd4 · Cited by 24
Cupello, A. (2003) · Amino Acids · doi:10.1007/s00726-002-0350-4 · Cited by 24
Nothdurfter, C., Rupprecht, R., & Rammes, G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799078748 · Cited by 24
Fine mapping of a sedative‐hypnotic drug withdrawal locus on mouse chromosome 11
Hood, H. M., Metten, P., Crabbe, J. C., & Buck, K. J. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00122.x · Cited by 24
Costanzo, A., Guerrini, G., Ciciani, G., Bruni, F., Costagli, C., Selleri, S., Besnard, F., Costa, B., Martini, C., & Malmberg‐Aiello, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020944u · Cited by 24
Mitchinson, A., Atack, J. R., Blurton, P., Carling, R. W., Castro, J. L., Curley, K. S., Russell, M. G. N., Marshall, G. R., McKernan, R. M., Moore, K. W., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.085 · Cited by 24
Self-citationAtack, J. R., Pike, A., Clarke, A., Cook, S. M., Sohal, B., McKernan, R. M., & Dawson, G. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006973 · Cited by 23
“A complimentary approach has been to use subtype-selective compounds to characterise the behaviour consequences of affecting only certain GABAA subtypes (McKernan et al., 2000; Atack et al., 2005b).”
BackgroundMethodInfluentialSelf-citationA bibliometric analysis of the recent advances in diazepam from 2012 to 2021
Zhang, M., Kou, L., Qin, Y., Chen, J., Bai, D., Zhao, L., Lin, H., & Jiang, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1042594 · Cited by 23
Influence of GABAA Receptor α Subunit Isoforms on the Benzodiazepine Binding Site
Lüscher, B. P., Baur, R., Goeldner, M. P., & Sigel, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042101 · Cited by 23
Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task
Zanin, K. A., Patti, C. L., Sanday, L., Fernandes‐Santos, L., Oliveira, L. C., Poyares, D. R., Tufik, S., & Frussa‐Filho, R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2756-3 · Cited by 23
Cappelli, A., Anzini, M., Castriconi, F., Grisci, G., Paolino, M., Braile, C., Valenti, S., Giuliani, G., Vomero, S., Capua, A. D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00034 · Cited by 23
Optimization of substituted imidazobenzodiazepines as novel asthma treatments
Jahan, R., Stephen, M. R., Forkuo, G. S., Kodali, R., Guthrie, M. L., Nieman, A. N., Yuan, N. Y., Zahn, N. M., Poe, M. M., Li, G., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.045 · Cited by 23
Liu, J., Chen, T., Norris, T., Knappenberger, K., Huston, J., Wood, M. W., & Bostwick, R. J. (2008) · Assay and Drug Development Technologies · doi:10.1089/adt.2008.161 · Cited by 23
Guerrini, G., Ciciani, G., Cambi, G., Bruni, F., Selleri, S., Besnard, F., Montali, M., Martini, C., Ghelardini, C., Galeotti, N., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.053 · Cited by 23
Laere, K. V., Bormans, G. M., Bohorquez, S. M. S., de Groot, T., Dupont, P. J., Lepeleire, I. D., Hoon, J. N. J. M. D., Mortelmans, L. A., Hargreaves, R. J., Atack, J. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.021 · Cited by 24
Self-citationThe GABA A Receptor: Subunit-Dependent Functions and Absence Seizures
Wong, C. G.-T., & Snead, O. C. (2001) · Epiliepsy currents/Epilepsy currents · doi:10.1046/j.1535-7597.2001.00009.x · Cited by 23
Paronis, C. A., Cox, E. D., Cook, J. R., & Bergman, J. (2001) · Psychopharmacology · doi:10.1007/s002130100754 · Cited by 23
Comparative biology of sleep in diverse animals
Lakhiani, R., Shanavas, S., & Melnattur, K. V. (2023) · Journal of Experimental Biology · doi:10.1242/jeb.245677 · Cited by 23
Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain
Lorenz‐Guertin, J. M., Povysheva, N. V., Chapman, C. A., MacDonald, M. L., Fazzari, M., Nigam, A., Nuwer, J. L., Das, S., Brady, M. L., Vajn, K., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106248 · Cited by 22
Jacobson‐Pick, S., Audet, M., McQuaid, R. J., Kalvapalle, R., & Anisman, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.038 · Cited by 22
Atack, J. R. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_2 · Cited by 23
Self-citationRigamonti, M., Prestat, G., Broggini, G., & Poli, G. (2013) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2013.11.010 · Cited by 22
Guerrini, G., Ciciani, G., Cambi, G., Bruni, F., Selleri, S., Guarino, C., Melani, F., Montali, M., Martini, C., Ghelardini, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801599a · Cited by 22
Fahey, J. M., Grassi, J. M., Reddi, J. M., & Greenblatt, D. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.006 · Cited by 22
Stephens, D. N., Mead, A. N., & Ripley, T. L. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00004 · Cited by 22
MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear learning
Zhang, Y., Zhu, Y., Cao, S.-X., Sun, P., Yang, J.-M., Xia, Y., Xie, S., Yu, X.-D., Fu, J., Shen, C.-J., et al. (2020) · eLife · doi:10.7554/elife.55342 · Cited by 21
Kalinowski, D., Bogus‐Nowakowska, K., Kozłowska, A., & Równiak, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-28069-2 · Cited by 21
Solid-Phase Synthesis of Trisubstituted Benzo[1,4]-Diazepin-5-one Derivatives
Fülöpová, V., Gucký, T., Grepl, M., & Soural, M. (2012) · ACS Combinatorial Science · doi:10.1021/co300124q · Cited by 21
Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain
Lara, C. O., Burgos, C. F., Moraga‐Cid, G., Carrasco, M. A., & Yévenes, G. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00167 · Cited by 22
Sánchez-Lemus, E., Honda, M., & Saavedra, J. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.041 · Cited by 21
Guerrini, G., Ciciani, G., Bruni, F., Selleri, S., Martini, C., Daniele, S., Ghelardini, C., Mannelli, L. D. C., & Costanzo, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.047 · Cited by 21
Anxiolytic-like effect of Aronia melanocarpa fruit juice in rats
Valcheva-Kuzmanova, S., & Zhelyazkova-Savova, M. (2009) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2009.31.10.1423884 · Cited by 21
Vijayan, R., Bera, I., Manoharan, P., Saha, S., & Ghoshal, N. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900309s · Cited by 21
Geracitano, R., Fischer, D., Kasugai, Y., Ferraguti, F., & Capogna, M. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00032 · Cited by 21
Lack of inhibition leads to abuse
Riegel, A. C., & Kalivas, P. W. (2010) · Nature · doi:10.1038/463743a · Cited by 21
Sarantis, K., Sotiriou, E., Papatheodoropoulos, C., Matsokis, N. A., & Angelatou, F. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.016 · Cited by 22
McMahon, L. R., Gerak, L. R., & France, C. P. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29497-0 · Cited by 21
Huang, X., Cao, H., Zhang, C., Lan, H., Gong, X., Li, R., Lin, Y., Xu, B., Chen, H., & Guan, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1143784 · Cited by 20
Guerrini, G., Ciciani, G., Bruni, F., Selleri, S., Melani, F., Daniele, S., Martini, C., & Costanzo, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.009 · Cited by 20
Auta, J., Kadriu, B., Giusti, P., Costa, E., & Guidotti, A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.016 · Cited by 20
Shanmugasundaram, J., Viswanathan, S., Nadipelly, J., Kathirvelu, P., Sayeli, V., & Cheriyan, B. V. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.05.009 · Cited by 20
Ion Channel Blockers for the Treatment of Neuropathic Pain
Colombo, E. V., Francisconi, S., Faravelli, L., Izzo, E., & Pevarello, P. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.19 · Cited by 20
Fischer, B. D., Teixeira, L. P., Linn, M. L. V., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2975-2 · Cited by 20
Wasowski, C., Gavernet, L., Barrios, I. A., Villalba, M. L., Pastore, V., Samaja, G. A., Enrique, A., Bruno‐Blanch, L. E., & Marder, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.015 · Cited by 20
Ishikawa, M., Otaka, M., Neumann, P. A., Wang, Z., Cook, J. M., Schlüter, O. M., Dong, Y., & Huang, Y. H. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.262915 · Cited by 20
Auta, J., Gatta, E., Davis, J. M., Pandey, S. C., & Guidotti, A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.416 · Cited by 20
Vinkers, C. H., Olivier, B., Hanania, T., Min, W., Schreiber, R., Hopkins, S. C., Campbell, U. C., & Paterson, N. E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.054 · Cited by 20
New and investigational antiepileptic drugs
Striano, P., & Striano, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903369341 · Cited by 20
Tanaka, M., Suemaru, K., Watanabe, S., Cui, R., Li, B., & Araki, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071991 · Cited by 20
McMahon, L. R., & France, C. P. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706550 · Cited by 20
Jennings, A. S. R., Lewis, R. T., Russell, M. G. N., Hallett, D. J., Street, L. J., Castro, J. L., Atack, J. R., Cook, S. M., Lincoln, R. J., Stanley, J. L., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.044 · Cited by 20
Self-citationNovel Benzodiazepines A review of the evidence of use and harms of Novel Benzodiazepines
Campbell, A., & VARIOUS AUTHORS, A. (2020) · Research Portal (Queen's University Belfast) · Cited by 20
Search for α3β2/3γ2 subtype selective ligands that are stable on human liver microsomes
Namjoshi, O. A., Wang, Z.-J., Rallapalli, S., Johnson, E. M., Johnson, Y.-T., Ng, H. H., Ramerstorfer, J., Varagić, Z., Sieghart, W., Majumder, S., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.057 · Cited by 19
Chagraoui, A., Skiba, M., Thuillez, C., & Thibaut, F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.08.001 · Cited by 19
Herd, M. B., Lambert, J. J., & Belelli, D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12601 · Cited by 19
Biggerstaff, A., Kivell, B. M., Smith, J. L., Mian, M. Y., Golani, L. K., Rashid, F., Sharmin, D., Knutson, D. E., Cerne, R., Cook, J. M., et al. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172996 · Cited by 19
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects
Knutson, D. E., Smith, J. L., Ping, X., Jin, X., Golani, L. K., Li, G., Tiruveedhula, V. V. N. P. B., Rashid, F., Mian, M. Y., Jahan, R., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00295 · Cited by 19
Masneuf, S., Buetler, J., Koester, C., & Crestani, F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01763.x · Cited by 19
Reproductive experience reduces the sedative, but not anxiolytic effects of diazepam
Byrnes, E. M., & Bridges, R. S. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.05.008 · Cited by 19
Terzano, M. G., Parrino, L., Bonanni, E., Cirignotta, F., Ferrillo, F., Gigli, G. L., Savarese, M., & Ferini‐Strambi, L. (2005) · Clinical Drug Investigation · doi:10.2165/00044011-200525120-00002 · Cited by 19
Catatonia in French Psychiatry: Implications of the Zolpidem Challenge Test
(2007) · Psychiatric Annals · doi:10.3928/00485713-20070101-02 · Cited by 19
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology
Möhler, H. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.3/hmoehler · Cited by 19
(2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80053-7 · Cited by 19
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
Berezhnoy, D., Gravielle, M. C., Downing, S., Kostakis, E., Basile, A. S., Skolnick, P., Gibbs, T. T., & Farb, D. H. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-11 · Cited by 18
“α5 subunits are thought to be responsible for the impairment of learning and memory that is induced by BZDs [28].”
BackgroundInfluentialAminzadeh, F. M., & Zeynizadeh, B. (2023) · Nanoscale Advances · doi:10.1039/d3na00415e · Cited by 18
Guet-McCreight, A., Chameh, H. M., Mazza, F., Prévot, T. D., Valiante, T. A., Sibille, E. L., & Hay, E. (2024) · Communications Biology · doi:10.1038/s42003-024-05907-1 · Cited by 19
de Bartolomeis, A., Avvisati, L., Iasevoli, F., & Tomasetti, C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.034 · Cited by 18
Gurrell, R., Iredale, P., Evrard, A., Duveau, V., Ruggiero, C., & Roucard, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13927 · Cited by 18
Magaji, M. G., Musa, A. M., Abdullahi, M. I., Ya’u, J., & Hussaini, I. M. (2015) · PubMed Central · Cited by 18
Saavedra, J. M., & Pavel, J. (2005) · Drug Development Research · doi:10.1002/ddr.20027 · Cited by 18
Khosravi, M., Khakpour, S., Adibi, L., & Jahromy, M. H. (2014) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2014.410046 · Cited by 18
Developing dual functional allosteric modulators of GABAA receptors
Liu, X. F., Chang, H., Schmiesing, R. J., Wesolowski, S. S., Knappenberger, K. S., Arriza, J. L., & Chapdelaine, M. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.09.058 · Cited by 18
Leslie, J. C., Norwood, K., Kennedy, P. J., Begley, M., & Shaw, D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2710-4 · Cited by 18
Morales, M., Varlinskaya, E. I., & SPEAR, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.004 · Cited by 18
Drexler, B., Zinser, S., Huang, S., Poe, M. M., Rudolph, U., Cook, J. M., & Antkowiak, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.034 · Cited by 18
SILVA, A. Q. D., Nilin, J., Loureiro, S., & Costa-Lotufo, L. V. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020180595 · Cited by 18
Farajdokht, F., Vosoughi, A., Ziaee, M., Araj‐Khodaei, M., Mahmoudi, J., & Sadigh‐Eteghad, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05699-7 · Cited by 18
Faulkner, M. A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s55930 · Cited by 18
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.